A 58-Year-Old With a Neck Lump and a Normal Fine-Needle Aspirate
A 58-year-old man presents with a 4 cm, painless, hard left neck mass in level II that he noticed 3 months ago. He has a 40-pack-year smoking history and drinks 2–3 units of alcohol daily. He denies hoarseness, dysphagia, or weight loss. Examination of the oral cavity, oropharynx, and larynx with a flexible nasendoscope is normal. A fine-needle aspiration (FNA) of the neck mass is reported as "reactive lymphoid tissue, no malignant cells." A CT scan with contrast shows a 4 cm necrotic level II lymph node with no obvious primary site. The patient is anxious and asks whether he needs surgery.
1. How do you interpret the FNA result, and what is your next step?
Read the worked answer
A "reactive lymphoid tissue" FNA in a 58-year-old smoker with a 4 cm hard, necrotic level II lymph node is not reassuring. FNA has a false-negative rate of 10–20% for head and neck masses, especially for cystic or necrotic nodes, and for HPV-related oropharyngeal squamous cell carcinoma. The CT finding of a necrotic node is highly suspicious for malignancy.
Next step: excision biopsy or core biopsy of the node, preferably with a repeat FNA or core needle biopsy under ultrasound guidance. Excision biopsy is preferred if the node is accessible and the diagnosis remains unclear, because it provides architecture and allows HPV testing (p16 immunohistochemistry) and EBER for Epstein-Barr virus. Do not proceed to neck dissection without a tissue diagnosis unless the clinical picture is overwhelmingly malignant and the patient is unfit for biopsy. In that case, a panendoscopy with directed biopsies is performed first.
2. What is the workup for a suspected unknown primary, and how does HPV status change management?
Read the worked answer
Workup for unknown primary:
- History and examination: full head and neck exam, including flexible nasendoscopy, palpation of the oral cavity, oropharynx, and nasopharynx.
- Imaging: CT/MRI of the neck and PET-CT to identify a primary or distant metastases.
- Panendoscopy with directed biopsies: tonsillectomy (ipsilateral or bilateral) and base of tongue biopsies, plus nasopharyngeal and hypopharyngeal biopsies. This is the gold standard for finding an occult primary.
- HPV and EBV testing: p16 immunohistochemistry and HPV DNA on the node; EBER for nasopharyngeal primary.
How HPV status changes management:
- HPV-positive (p16-positive) disease is usually oropharyngeal squamous cell carcinoma. It has a better prognosis and is treated with definitive chemoradiotherapy or surgery (transoral robotic surgery) plus neck dissection. De-escalation trials are ongoing.
- HPV-negative disease is more aggressive and requires standard chemoradiotherapy or surgery with adjuvant therapy.
- EBV-positive suggests nasopharyngeal carcinoma, which is treated with chemoradiotherapy.
- If no primary is found after panendoscopy, treat the neck with surgery (neck dissection) or radiotherapy to the neck and potential primary sites (e.g., bilateral tonsils and base of tongue).
3. What are the ethical considerations in discussing treatment options with this patient?
Read the worked answer
- Informed consent: Explain the uncertainty of the diagnosis, the purpose of biopsy, and the risks of surgery (bleeding, infection, nerve injury, scar).
- Truthfulness: Do not overstate the benign nature of the FNA. Explain that the FNA can miss cancer and that further tests are needed.
- Shared decision-making: Discuss the options (excision biopsy vs. observation vs. repeat FNA) and the consequences of delay.
- Confidentiality and privacy: Ensure the patient understands who will see the results and how they will be communicated.
- Cultural and language considerations: Use an interpreter if needed and involve family only with consent.
- Avoiding harm: Do not perform unnecessary surgery without a diagnosis, but do not delay diagnosis of a potentially curable cancer.